The United States plans to raise tariffs on car imports from the EU to 25%, accusing the European Union of violating a trade agreement. The European Commission rejects these accusations and is prepared to defend the interests of the EU.
The United States is introducing new tariffs on patented medicines and their components, reaching up to 100% for major companies. Generics and biosimilars are currently exempt from these tariffs, and certain countries and agreements are granted special benefits. These measures are aimed at encouraging investment in the American pharmaceutical industry.